CERo Therapeutics Holdings, Inc. Common Stock Cash Flow Quality Index
CERo Therapeutics Holdings, Inc. Common Stock cash flow quality index. CERo Therapeutics Holdings, Inc. Common Stock (CERO) has a Cash Flow Quality Index of -2.06x as of September 2022. Operating cash flow of $-174.35K is below net income of $84.50K, suggesting accrual-heavy earnings not yet converted to cash. See CERo Therapeutics Holdings, Inc. Common financial flexibility index to measure the company's free cash flow as a share of total liabilities.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
CERo Therapeutics Holdings, Inc. Common Stock Cash Flow Quality Index by Year (None–None)
CERo Therapeutics Holdings, Inc. Common Stock cash flow quality index by year from None to None. Year-by-year earnings quality comparison for CERo Therapeutics Holdings, Inc. Common Stock. For the full cash flow conversion analysis, see CERo Therapeutics Holdings, Inc. Common (CERO) cash flow conversion.
| Year | Quality Index | Operating CF (USD) | Net Income | YoY Change |
|---|